Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemiaMaribel Forero‐Castro, Jesús María Hernández‐Rivas, María Hernández‐Sánchez et al.|British Journal of Cancer|2017Cited by 51
Wilms Tumor 1 gene expression levels improve risk stratification in <scp>AML</scp> patients. Results of a multicentre study within the Spanish Group for Molecular Biology in HaematologyCarolina Martínez‐Laperche, Mi Kwon, Ana Carolina Franco-Villegas et al.|British Journal of Haematology|2017Cited by 4
Validation of mutated <i>CEBPA</i> bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registryEsther Prados de la Torre, Pau Montesinos, Josefina Serrano et al.|Haematologica|2024Cited by 3